Today's trail

Synaptics Astra SR200 AI Chips: Specs and Availability

Samsung, SK Hynix Upgrade China Plants for Advanced Memory Chips Amid AI Demand as US Export Curbs Persis

Tether leads $15 million funding round for AI-focused payment startup Mural

The Series A round, which included participation from North Island Ventures and existing investors, brings New York-based Mural's total funding to $28 million.

What AI agents can and can’t do in the recording studio

OpenAI is acquiring startup Orchestra Bio and plans to merge it with its life sciences AI platform Rosalind. The goal is to build AI agents that help pharma teams coordinate drug development, from tracking trials to spotting problems. Developing a new drug in the US takes ten to 15 years on average. OpenAI already works with Novo Nordisk and Moderna on AI-driven pharma research.

DeepSeek open-sources DeepInfer, the engine serving 155T tokens a day

Visier Showcases Expanded Workforce Context Engine, The AI Foundation for Enterprise HR

Enterprises are deploying AI agents on top of incomplete and siloed workforce data that sit scattered across HR and finance systems and a decade of point solutions, each with its own definitions and blind spots.

Kinsus Bets NT$23.5B on AI Chip Substrates [2026]

Kinsus Interconnect approves NT$23.5B capex for AI chip ABF substrates, expanding its K6 plant as AI revenue share climbs toward 15% by 2026.

OpenAI acquires Orchestra Bio to build AI agents that speed up drug development

Forrester’s 2027 B2B Go-To-Market Predictions: AI Agents Will Influence 75% of B2B Purchase Decisions

Some of the most interesting moments in music production come when an arrangement won’t work. The groove is there and the melody is promising, but something